D
Escalon Medical Corp.
ESMC
$0.208
$0.000.00%
D
Sell
2/18/2025Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 2/18/2025 due to an increase in the total return index, efficiency index and growth index. EBIT increased 1,047.78% from -$27 to $255.9, net income increased 863.98% from -$32.2 to $246, and operating cash flow increased 803.6% from $33.3 to $300.9.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 2/18/2025 due to an increase in the total return index, efficiency index and growth index. EBIT increased 1,047.78% from -$27 to $255.9, net income increased 863.98% from -$32.2 to $246, and operating cash flow increased 803.6% from $33.3 to $300.9.
D
Sell
10/2/2024Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 10/2/2024 due to a significant decline in the valuation index, efficiency index and total return index.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 10/2/2024 due to a significant decline in the valuation index, efficiency index and total return index.
D
Sell
3/25/2024Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 3/25/2024 due to a decline in the volatility index, efficiency index and valuation index. Net income declined 259.91% from -$21.2 to -$76.3, and total capital declined 6.21% from $2.71M to $2.55M.
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 3/25/2024 due to a decline in the volatility index, efficiency index and valuation index. Net income declined 259.91% from -$21.2 to -$76.3, and total capital declined 6.21% from $2.71M to $2.55M.
C
Hold
12/18/2023Downgrade
Escalon Medical Corp. (ESMC) was downgraded to C- from C on 12/18/2023 due to a significant decline in the growth index and total return index. Earnings per share declined from $0.0002 to -$0.0046, operating cash flow declined 132.69% from $354.9 to -$116, and EBIT declined 107.61% from $204.9 to -$15.6.
Escalon Medical Corp. (ESMC) was downgraded to C- from C on 12/18/2023 due to a significant decline in the growth index and total return index. Earnings per share declined from $0.0002 to -$0.0046, operating cash flow declined 132.69% from $354.9 to -$116, and EBIT declined 107.61% from $204.9 to -$15.6.
C
Hold
8/30/2023Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C from C- on 8/30/2023 due to a noticeable increase in the total return index.
Escalon Medical Corp. (ESMC) was upgraded to C from C- on 8/30/2023 due to a noticeable increase in the total return index.
C
Hold
8/15/2023Downgrade
Escalon Medical Corp. (ESMC) was downgraded to C- from C on 8/15/2023 due to a decline in the efficiency index and total return index.
Escalon Medical Corp. (ESMC) was downgraded to C- from C on 8/15/2023 due to a decline in the efficiency index and total return index.
C
Hold
7/31/2023Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C from C- on 7/31/2023 due to a substantial increase in the total return index and volatility index.
Escalon Medical Corp. (ESMC) was upgraded to C from C- on 7/31/2023 due to a substantial increase in the total return index and volatility index.
C
Hold
6/28/2023Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 6/28/2023 due to a noticeable increase in the total return index and volatility index.
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 6/28/2023 due to a noticeable increase in the total return index and volatility index.
D
Sell
5/30/2023Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 5/30/2023 due to a significant increase in the growth index, efficiency index and volatility index. Net income increased 9,853.33% from -$6 to $585.2, earnings per share increased from -$0.0026 to $0.0434, and operating cash flow increased 505.03% from $39.8 to $240.8.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 5/30/2023 due to a significant increase in the growth index, efficiency index and volatility index. Net income increased 9,853.33% from -$6 to $585.2, earnings per share increased from -$0.0026 to $0.0434, and operating cash flow increased 505.03% from $39.8 to $240.8.
D
Sell
3/24/2023Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 3/24/2023 due to an increase in the volatility index and total return index.
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 3/24/2023 due to an increase in the volatility index and total return index.
D
Sell
3/9/2023Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 3/9/2023 due to a decline in the volatility index.
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 3/9/2023 due to a decline in the volatility index.
D
Sell
2/22/2023Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 2/22/2023 due to an increase in the growth index and efficiency index. Operating cash flow increased 112.82% from -$310.4 to $39.8, EBIT increased 100% from -$315.9 to $0, and net income increased 98.13% from -$320.7 to -$6.
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 2/22/2023 due to an increase in the growth index and efficiency index. Operating cash flow increased 112.82% from -$310.4 to $39.8, EBIT increased 100% from -$315.9 to $0, and net income increased 98.13% from -$320.7 to -$6.
D
Sell
11/21/2022Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 11/21/2022 due to a major decline in the efficiency index, volatility index and solvency index. Net income declined 741.4% from $50 to -$320.7, debt to equity increased from 0.8 to 1.31, and total capital declined 14.74% from $2.68M to $2.29M.
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 11/21/2022 due to a major decline in the efficiency index, volatility index and solvency index. Net income declined 741.4% from $50 to -$320.7, debt to equity increased from 0.8 to 1.31, and total capital declined 14.74% from $2.68M to $2.29M.
D
Sell
5/16/2022Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 5/16/2022 due to a significant decline in the valuation index, efficiency index and growth index. EBIT declined 494.5% from -$49.1 to -$291.9, net income declined 456.39% from -$53.2 to -$296, and earnings per share declined from -$0.01 to -$0.0417.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 5/16/2022 due to a significant decline in the valuation index, efficiency index and growth index. EBIT declined 494.5% from -$49.1 to -$291.9, net income declined 456.39% from -$53.2 to -$296, and earnings per share declined from -$0.01 to -$0.0417.
D
Sell
3/21/2022Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 3/21/2022 due to an increase in the volatility index and total return index.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 3/21/2022 due to an increase in the volatility index and total return index.
D
Sell
2/16/2022Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 2/16/2022 due to a noticeable decline in the growth index, total return index and valuation index. Earnings per share declined from $0.02 to -$0.0089.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 2/16/2022 due to a noticeable decline in the growth index, total return index and valuation index. Earnings per share declined from $0.02 to -$0.0089.
D
Sell
2/2/2022Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 2/2/2022 due to a major decline in the total return index.
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 2/2/2022 due to a major decline in the total return index.
C
Hold
11/17/2021Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C- from D- on 11/17/2021 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 72.86% from $183.5 to $317.2, debt to equity declined from 1.4 to 0.56, and the quick ratio increased from 0.8 to 0.9.
Escalon Medical Corp. (ESMC) was upgraded to C- from D- on 11/17/2021 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 72.86% from $183.5 to $317.2, debt to equity declined from 1.4 to 0.56, and the quick ratio increased from 0.8 to 0.9.
D
Sell
11/8/2021Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and valuation index.
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and valuation index.
D
Sell
7/15/2021Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 7/15/2021 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from $0.0078 to -$0.02, EBIT declined 227.36% from $103.8 to -$132.2, and operating cash flow declined 29.9% from $175.6 to $123.1.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 7/15/2021 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from $0.0078 to -$0.02, EBIT declined 227.36% from $103.8 to -$132.2, and operating cash flow declined 29.9% from $175.6 to $123.1.
D
Sell
5/12/2021Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 5/12/2021 due to an increase in the valuation index and volatility index.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 5/12/2021 due to an increase in the valuation index and volatility index.
D
Sell
4/27/2021Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 4/27/2021 due to a decline in the valuation index.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 4/27/2021 due to a decline in the valuation index.
D
Sell
3/19/2021Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 3/19/2021 due to an increase in the total return index and volatility index.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 3/19/2021 due to an increase in the total return index and volatility index.
D
Sell
6/2/2020Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 6/2/2020 due to a substantial decline in the efficiency index, total return index and growth index. EBIT declined 88.68% from -$68 to -$128.3, and total revenue declined 13.96% from $2.74M to $2.36M.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 6/2/2020 due to a substantial decline in the efficiency index, total return index and growth index. EBIT declined 88.68% from -$68 to -$128.3, and total revenue declined 13.96% from $2.74M to $2.36M.
D
Sell
2/18/2020Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 2/18/2020 due to a significant decline in the valuation index, efficiency index and growth index. Operating cash flow declined 2,083.33% from $7.2 to -$142.8, earnings per share declined from $0.051 to -$0.0928, and net income declined 208.67% from $621.4 to -$675.3.
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 2/18/2020 due to a significant decline in the valuation index, efficiency index and growth index. Operating cash flow declined 2,083.33% from $7.2 to -$142.8, earnings per share declined from $0.051 to -$0.0928, and net income declined 208.67% from $621.4 to -$675.3.
C
Hold
12/17/2019Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 12/17/2019 due to an increase in the volatility index and total return index.
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 12/17/2019 due to an increase in the volatility index and total return index.
D
Sell
11/15/2019Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 11/15/2019 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 9,660% from -$6.5 to $621.4, earnings per share increased from $0.0013 to $0.05, and operating cash flow increased 107.11% from -$101.3 to $7.2.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 11/15/2019 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 9,660% from -$6.5 to $621.4, earnings per share increased from $0.0013 to $0.05, and operating cash flow increased 107.11% from -$101.3 to $7.2.
D
Sell
6/25/2019Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 6/25/2019 due to an increase in the total return index, volatility index and valuation index.
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 6/25/2019 due to an increase in the total return index, volatility index and valuation index.
D
Sell
6/10/2019Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 6/10/2019 due to a decline in the total return index and valuation index.
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 6/10/2019 due to a decline in the total return index and valuation index.
D
Sell
5/15/2019Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 5/15/2019 due to an increase in the growth index, efficiency index and total return index. Net income increased 110.18% from -$218 to $22.2, EBIT increased 109.8% from -$226.5 to $22.2, and earnings per share increased from -$0.0312 to $0.0008.
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 5/15/2019 due to an increase in the growth index, efficiency index and total return index. Net income increased 110.18% from -$218 to $22.2, EBIT increased 109.8% from -$226.5 to $22.2, and earnings per share increased from -$0.0312 to $0.0008.
D
Sell
4/25/2019Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 4/25/2019 due to a decline in the total return index and volatility index.
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 4/25/2019 due to a decline in the total return index and volatility index.
D
Sell
3/4/2019Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 3/4/2019 due to an increase in the total return index.
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 3/4/2019 due to an increase in the total return index.
D
Sell
2/15/2019Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 2/15/2019 due to a significant decline in the valuation index, growth index and total return index. Operating cash flow declined 2,307.63% from $11.8 to -$260.5, EBIT declined 421.89% from -$43.4 to -$226.5, and earnings per share declined from -$0.0082 to -$0.0312.
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 2/15/2019 due to a significant decline in the valuation index, growth index and total return index. Operating cash flow declined 2,307.63% from $11.8 to -$260.5, EBIT declined 421.89% from -$43.4 to -$226.5, and earnings per share declined from -$0.0082 to -$0.0312.
D
Sell
11/15/2018Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 11/15/2018 due to a decline in the volatility index and total return index.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 11/15/2018 due to a decline in the volatility index and total return index.
D
Sell
10/31/2018Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 10/31/2018 due to an increase in the volatility index, valuation index and total return index.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 10/31/2018 due to an increase in the volatility index, valuation index and total return index.
D
Sell
10/16/2018Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 10/16/2018 due to a decline in the volatility index, efficiency index and growth index. Operating cash flow declined 93.76% from $365.1 to $22.8.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 10/16/2018 due to a decline in the volatility index, efficiency index and growth index. Operating cash flow declined 93.76% from $365.1 to $22.8.
D
Sell
6/20/2018Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 6/20/2018 due to a decline in the total return index.
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 6/20/2018 due to a decline in the total return index.
C
Hold
6/5/2018Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 6/5/2018 due to an increase in the volatility index and valuation index.
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 6/5/2018 due to an increase in the volatility index and valuation index.
D
Sell
5/17/2018Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 5/17/2018 due to a noticeable decline in the growth index, valuation index and total return index. EBIT declined 137.66% from $245.1 to -$92.3, earnings per share declined from $0.09 to -$0.02, and total revenue declined 22.1% from $3.38M to $2.64M.
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 5/17/2018 due to a noticeable decline in the growth index, valuation index and total return index. EBIT declined 137.66% from $245.1 to -$92.3, earnings per share declined from $0.09 to -$0.02, and total revenue declined 22.1% from $3.38M to $2.64M.
C
Hold
4/30/2018Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 4/30/2018 due to a noticeable increase in the total return index and volatility index.
Escalon Medical Corp. (ESMC) was upgraded to C- from D+ on 4/30/2018 due to a noticeable increase in the total return index and volatility index.
D
Sell
2/16/2018Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 2/16/2018 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 1,275.54% from -$60.5 to $711.2, earnings per share increased from -$0.01 to $0.09, and EBIT increased 997.8% from -$27.3 to $245.1.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 2/16/2018 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 1,275.54% from -$60.5 to $711.2, earnings per share increased from -$0.01 to $0.09, and EBIT increased 997.8% from -$27.3 to $245.1.
D
Sell
11/16/2017Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 11/16/2017 due to a large increase in the growth index, efficiency index and volatility index. Net income increased 62.09% from -$159.6 to -$60.5, earnings per share increased from -$0.0211 to -$0.01, and total capital increased 0.73% from $1.98M to $1.99M.
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 11/16/2017 due to a large increase in the growth index, efficiency index and volatility index. Net income increased 62.09% from -$159.6 to -$60.5, earnings per share increased from -$0.0211 to -$0.01, and total capital increased 0.73% from $1.98M to $1.99M.
D
Sell
6/5/2017Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D- from E+ on 6/5/2017 due to an increase in the volatility index and total return index.
Escalon Medical Corp. (ESMC) was upgraded to D- from E+ on 6/5/2017 due to an increase in the volatility index and total return index.
E
Sell
5/18/2017Downgrade
Escalon Medical Corp. (ESMC) was downgraded to E+ from D- on 5/18/2017 due to a large decline in the growth index, efficiency index and solvency index. EBIT declined 73.88% from -$42.5 to -$73.9, net income declined 64.46% from -$65 to -$106.9, and earnings per share declined from -$0.01 to -$0.0142.
Escalon Medical Corp. (ESMC) was downgraded to E+ from D- on 5/18/2017 due to a large decline in the growth index, efficiency index and solvency index. EBIT declined 73.88% from -$42.5 to -$73.9, net income declined 64.46% from -$65 to -$106.9, and earnings per share declined from -$0.01 to -$0.0142.
D
Sell
2/17/2017Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D- from E+ on 2/17/2017 due to a noticeable increase in the growth index and efficiency index. EBIT increased 88.97% from -$385.3 to -$42.5, net income increased 83.57% from -$395.5 to -$65, and earnings per share increased from -$0.0524 to -$0.01.
Escalon Medical Corp. (ESMC) was upgraded to D- from E+ on 2/17/2017 due to a noticeable increase in the growth index and efficiency index. EBIT increased 88.97% from -$385.3 to -$42.5, net income increased 83.57% from -$395.5 to -$65, and earnings per share increased from -$0.0524 to -$0.01.
E
Sell
12/2/2016Downgrade
Escalon Medical Corp. (ESMC) was downgraded to E+ from D- on 12/2/2016 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.77 to 0.49, and debt to equity increased from 0.14 to 0.18.
Escalon Medical Corp. (ESMC) was downgraded to E+ from D- on 12/2/2016 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.77 to 0.49, and debt to equity increased from 0.14 to 0.18.
D
Sell
10/14/2016Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D- from E+ on 10/14/2016 due to an increase in the efficiency index and valuation index.
Escalon Medical Corp. (ESMC) was upgraded to D- from E+ on 10/14/2016 due to an increase in the efficiency index and valuation index.
E
Sell
3/11/2016Downgrade
Escalon Medical Corp. (ESMC) was downgraded to E+ from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.03 to 0.89.
Escalon Medical Corp. (ESMC) was downgraded to E+ from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.03 to 0.89.
D
Sell
12/24/2015Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 12/24/2015 due to an increase in the volatility index.
Escalon Medical Corp. (ESMC) was upgraded to D from D- on 12/24/2015 due to an increase in the volatility index.
D
Sell
11/18/2015Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 11/18/2015 due to a decline in the volatility index, growth index and valuation index. Earnings per share declined from $0.0075 to -$0.04.
Escalon Medical Corp. (ESMC) was downgraded to D- from D on 11/18/2015 due to a decline in the volatility index, growth index and valuation index. Earnings per share declined from $0.0075 to -$0.04.
D
Sell
9/29/2015Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 9/29/2015 due to a major decline in the efficiency index, growth index and total return index. Total capital declined 1.6% from $3.04M to $2.99M.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 9/29/2015 due to a major decline in the efficiency index, growth index and total return index. Total capital declined 1.6% from $3.04M to $2.99M.
D
Sell
9/14/2015Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 9/14/2015 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from -$0.0098 to $0.0075, EBIT declined 109.64% from -$76.8 to $7.4, and operating cash flow declined 24.56% from -$126.2 to -$95.2.
Escalon Medical Corp. (ESMC) was downgraded to D+ from C- on 9/14/2015 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from -$0.0098 to $0.0075, EBIT declined 109.64% from -$76.8 to $7.4, and operating cash flow declined 24.56% from -$126.2 to -$95.2.
C
Hold
2/13/2015Upgraded
Escalon Medical Corp. (ESMC) was upgraded to C- from D on 2/13/2015 due to a substantial increase in the volatility index, growth index and efficiency index. Total revenue increased 40.66% from $2.63M to $3.7M.
Escalon Medical Corp. (ESMC) was upgraded to C- from D on 2/13/2015 due to a substantial increase in the volatility index, growth index and efficiency index. Total revenue increased 40.66% from $2.63M to $3.7M.
D
Sell
11/14/2014Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 11/14/2014 due to a noticeable decline in the volatility index, growth index and efficiency index. Total capital declined 12.72% from $3.46M to $3.02M, and total revenue declined 12.14% from $2.99M to $2.63M.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 11/14/2014 due to a noticeable decline in the volatility index, growth index and efficiency index. Total capital declined 12.72% from $3.46M to $3.02M, and total revenue declined 12.14% from $2.99M to $2.63M.
D
Sell
9/26/2014Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 9/26/2014 due to an increase in the volatility index, efficiency index and total return index.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 9/26/2014 due to an increase in the volatility index, efficiency index and total return index.
D
Sell
9/15/2014Downgrade
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 9/15/2014 due to a substantial decline in the volatility index.
Escalon Medical Corp. (ESMC) was downgraded to D from D+ on 9/15/2014 due to a substantial decline in the volatility index.
D
Sell
5/16/2014Upgraded
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 5/16/2014 due to an increase in the growth index, volatility index and efficiency index. Total revenue increased 2.38% from $3.08M to $3.15M, and total capital increased 2.36% from $3.74M to $3.83M.
Escalon Medical Corp. (ESMC) was upgraded to D+ from D on 5/16/2014 due to an increase in the growth index, volatility index and efficiency index. Total revenue increased 2.38% from $3.08M to $3.15M, and total capital increased 2.36% from $3.74M to $3.83M.
OTC PK
03/10/2025 9:30AM Eastern
Quotes delayed
